<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7815555" created="20/06/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7815555</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Characterization of the <term id="T1" lex="CD48_gene" sem="DNA_domain_or_region">CD48 gene</term> demonstrates a positive element that is specific to <term id="T2" lex="Epstein-Barr_virus-immortalized_B-cell_line" sem="Cell_natural"><term id="T3" lex="Epstein-Barr_virus" sem="Virus">Epstein-Barr virus</term>-immortalized <term id="A5" sem="Cell_natural">B-cell lines</term></term> and contains an essential <term id="T4" lex="NF-kappa_B_site" sem="DNA_domain_or_region"><term id="T5" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> site</term>.</sentence>
<event KT="Other" id="E150">
<type class="Physiological_process"/>
<theme idref="A5"/>
<clue>Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-<clueType>immortalized</clueType> B-cell lines and contains an essential NF-kappa B site.</clue>
</event>
<event KT="Other" id="E151">
<type class="Positive_regulation"/>
<theme idref="E150"/>
<cause idref="T3"/>
<clue>Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-<clueType>immortalized</clueType> B-cell lines and contains an essential NF-kappa B site.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T6" lex="Epstein-Barr_virus" sem="Virus">Epstein-Barr virus</term> (<term id="T7" lex="EBV" sem="Virus">EBV</term>) infection of mature, <term id="T8" lex="resting_B_cell" sem="Cell_natural">resting B cells</term> drives them to become <term id="A2" sem="Cell_natural">lymphoblasts</term> expressing high levels of cell surface molecules, such as <term id="T9" lex="CD48" sem="Protein_molecule">CD48</term>, characteristically expressed on <term id="T10" lex="normal_activated_B_cell" sem="Cell_natural">normal activated <term id="A3" sem="Cell_natural">B cells</term></term>.</sentence>
<event KT="Other" id="E1">
<type class="Initiation_of_viral_infection"/>
<theme idref="T7"/>
<theme idref="T8"/>
<clue>Epstein-Barr virus (EBV) <clueType>infection</clueType> <linkTheme>of</linkTheme> mature, resting B cells drives them to become lymphoblasts expressing high levels of cell surface molecules, such as CD48, characteristically expressed on normal activated B cells.</clue>
</event>
<event KT="Other" id="E102">
<type class="Cell_differentiation"/>
<theme idref="T8"/>
<theme idref="A2"/>
<clue>Epstein-Barr virus (EBV) infection of mature, resting B cells drives <corefTheme idref1="T8">them</corefTheme> to <clueType>become</clueType> lymphoblasts expressing high levels of cell surface molecules, such as CD48, characteristically expressed on normal activated B cells.</clue>
</event>
<event KT="Fact" id="E103">
<type class="Positive_regulation"/>
<theme idref="E102"/>
<cause idref="E1"/>
<clue>Epstein-Barr virus (EBV) infection of mature, resting B cells <clueType>drives</clueType> them to become lymphoblasts expressing high levels of cell surface molecules, such as CD48, characteristically expressed on normal activated B cells.</clue>
</event>
<event KT="Other" id="E3">
<type class="Gene_expression"/>
<theme idref="T9"/>
<clue>Epstein-Barr virus (EBV) infection of mature, resting B cells drives them to become <clueLoc>lymphoblasts</clueLoc> <clueType>expressing</clueType> high levels of cell surface molecules, such as CD48, characteristically expressed on normal activated B cells.</clue>
</event>
<event KT="Other" id="E4">
<type class="Gene_expression"/>
<theme idref="T9"/>
<clue>Epstein-Barr virus (EBV) infection of mature, resting B cells drives them to become lymphoblasts expressing high levels of cell surface molecules, such as CD48, characteristically <clueType>expressed</clueType> on <clueLoc>normal activated B cells.</clueLoc></clue>
</event>
<event KT="Other" id="E5">
<type class="Physiological_process"/>
<theme idref="A3"/>
<clue>Epstein-Barr virus (EBV) infection of mature, resting B cells drives them to become lymphoblasts expressing high levels of cell surface molecules, such as CD48, characteristically expressed on normal <clueType>activated</clueType> B cells.</clue>
</event>
<sentence id="S3">Here, we report on the identification of an <term id="A4" sem="DNA_domain_or_region"><term id="T11" lex="enhancer_element" sem="DNA_domain_or_region">enhancer element</term> in the <term id="T12" lex="CD48_gene" sem="DNA_domain_or_region"><term id="T13" lex="CD48" sem="Protein_molecule">CD48</term> gene</term></term> which reproducibly confers strong <term id="T14" lex="transcriptional_activity" sem="Other">transcriptional activity</term> only in <term id="T15" lex="EBV-positive_B-lymphoblastoid_cell_line" sem="Cell_cultured"><term id="T16" lex="EBV" sem="Virus">EBV</term>-positive <term id="A21" sem="Cell_cultured">B-lymphoblastoid cell lines</term></term>.</sentence>
<event KT="Analysis" id="E6">
<type class="Positive_regulation"/>
<theme idref="T14"/>
<cause idref="A4"/>
<clue>Here, we report on the identification of an enhancer element in the CD48 gene which <clueKT>reproducibly</clueKT> <clueType>confers</clueType> strong transcriptional activity only <clueLoc>in EBV-positive B-lymphoblastoid cell lines.</clueLoc></clue>
<comment>TPS A4</comment></event>
<event KT="Other" id="E51">
<type class="Viral_life_cycle"/>
<theme idref="T16"/>
<theme idref="A21"/>
<clue>Here, we report on the identification of an enhancer element in the CD48 gene which reproducibly confers strong transcriptional activity only in EBV-<clueType>positive</clueType> B-lymphoblastoid cell lines.</clue>
</event>
<sentence id="S4">The element is not activated upon infection of established <term id="T17" lex="EBV-negative_B-cell_line" sem="Cell_cultured"><term id="T18" lex="EBV" sem="Virus">EBV</term>-negative B-cell lines</term>, indicating that <term id="T19" lex="EBV" sem="Virus">EBV</term> fails to drive these cells to a fully <term id="T20" lex="lymphoblastoid_phenotype" sem="Cell_natural">lymphoblastoid phenotype</term>.</sentence>
<event id="E7">
<type class="Initiation_of_viral_infection"/>
<theme idref="T19"/>
<theme idref="T17"/>
<clue>The element is not activated upon <clueType>infection</clueType> <linkTheme>of</linkTheme> established EBV-negative B-cell lines, indicating that EBV fails to drive these cells to a fully lymphoblastoid phenotype.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E8">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="E7"/>
<clue><corefTheme>The element</corefTheme> is <cluePolarity>not</cluePolarity> <clueType>activated</clueType> <linkCause>upon</linkCause> infection of established EBV-negative B-cell lines, indicating that EBV fails to drive these cells to a fully lymphoblastoid phenotype.</clue>
</event>
<event KT="Other" assertion="non-exist" id="E109" uncertainty="probable">
<type class="Cell_differentiation"/>
<theme idref="T17"/>
<theme idref="T20"/>
<clue>The element is not activated upon infection of established EBV-negative B-cell lines, indicating that EBV fails to drive <corefTheme idref1="T17">these cells</corefTheme> <linkTheme>to</linkTheme> a fully lymphoblastoid phenotype.</clue>
<comment>NO CLUETYPE</comment></event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E110" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E109"/>
<cause idref="T19"/>
<clue>The element is not activated upon infection of established EBV-negative B-cell lines, <clueKT><clueCL>indicating</clueCL></clueKT> that EBV <cluePolarity>fails</cluePolarity> to <clueType>drive</clueType> these cells to a fully lymphoblastoid phenotype.</clue>
</event>
<sentence id="S5">An <term id="T21" lex="NF-kappa_B_binding_site" sem="DNA_substructure"><term id="T22" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> binding site</term> is an essential component of the element but alone is not sufficient to account for the activity or the specificity of the element.</sentence>
<event KT="Fact" id="E10">
<type class="Positive_regulation"/>
<theme idref="A4"/>
<cause idref="T21"/>
<clue>An NF-kappa B binding site is an <clueType>essential</clueType> component of <corefTheme>the element</corefTheme> but alone is not sufficient to account for the activity or the specificity of the element.</clue>
</event>
<sentence id="S6">We have detected a specific <term id="T23" lex="nuclear_protein_complex" sem="Protein_complex">nuclear protein complex</term> that binds to the element and show that <term id="T24" lex="NF-kappa_B1" sem="Protein_molecule">NF-kappa B1</term> (<term id="T25" lex="p50" sem="Protein_molecule">p50</term>) is a part of this complex.</sentence>
<event id="E11">
<type class="Binding"/>
<theme idref="T23"/>
<theme idref="A4"/>
<clue>We have <clueKT>detected</clueKT> a specific nuclear protein complex that <clueType>binds</clueType> <linkTheme>to</linkTheme> <corefTheme idref1="A4">the element</corefTheme> and show that NF-kappa B1 (p50) is a part of this complex.</clue>
</event>
<event id="E52">
<type class="Binding"/>
<theme idref="T25"/>
<theme idref="A4"/>
<clue>We have <clueKT>detected</clueKT> a specific nuclear protein complex that <clueType>binds</clueType> <linkTheme>to</linkTheme> <corefTheme idref1="A4">the element</corefTheme> and show that NF-kappa B1 (p50) is a part of this complex.</clue>
</event>
<sentence id="S7">The <term id="T26" lex="EBV-encoded_latent_membrane_protein_1" sem="Protein_molecule"><term id="T27" lex="EBV" sem="Virus">EBV</term>-encoded latent membrane protein 1</term> is capable of transactivating the <term id="A6" sem="DNA_domain_or_region">isolated <term id="A8" sem="DNA_domain_or_region"><term id="T28" lex="CD48" sem="Protein_molecule">CD48</term> <term id="T29" lex="NF-kappa_B_site" sem="DNA_domain_or_region"><term id="T30" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> site</term></term></term> but not the <term id="T31" lex="intact_element" sem="DNA_domain_or_region"><term id="A7" sem="DNA_domain_or_region">intact</term> element</term>, suggesting that the <term id="T32" lex="latent_membrane_protein_1-driven_activation" sem="Other"><term id="T33" lex="latent_membrane_protein_1" sem="Protein_molecule">latent membrane protein 1</term>-driven activation</term> of <term id="T34" lex="NF-kappa_B/Rel" sem="Protein_molecule">NF-kappa B/Rel</term> must interact with <term id="A10" sem="Other">other regulatory pathways</term> to control expression of <term id="A9" sem="DNA_family_or_group">cellular genes</term> as <term id="T35" lex="EBV" sem="Virus">EBV</term> drives <term id="T36" lex="resting_B_cell" sem="Cell_natural">resting <term id="A20" sem="Cell_natural">B cells</term></term> into the <term id="T37" lex="cell_cycle" sem="Other">cell cycle</term>.</sentence>
<event CL="L2" KT="Analysis" id="E12">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="T26"/>
<clue>The EBV-encoded latent membrane protein 1 is <clueKT><clueCL>capable of</clueCL></clueKT> <clueType>transactivating</clueType> the isolated CD48 NF-kappa B site but not the intact element, suggesting that the latent membrane protein 1-driven activation of NF-kappa B/Rel must interact with other regulatory pathways to control expression of cellular genes as EBV drives resting B cells into the cell cycle.</clue>
<comment>TPS A6</comment></event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E13">
<type class="Positive_regulation"/>
<theme idref="A7" idref1="A8"/>
<cause idref="T26"/>
<clue>The EBV-encoded latent membrane protein 1 is <clueKT><clueCL>capable of</clueCL></clueKT> <clueType>transactivating</clueType> the isolated CD48 NF-kappa B site but <cluePolarity>not</cluePolarity> the intact <corefTheme>element</corefTheme>, suggesting that the latent membrane protein 1-driven activation of NF-kappa B/Rel must interact with other regulatory pathways to control expression of cellular genes as EBV drives resting B cells into the cell cycle.</clue>
</event>
<event KT="Other" id="E14">
<type class="Positive_regulation"/>
<theme idref="T34"/>
<cause idref="T33"/>
<clue>The EBV-encoded latent membrane protein 1 is capable of transactivating the isolated CD48 NF-kappa B site but not the intact element, suggesting that the latent membrane protein 1-<linkCause>driven</linkCause> <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B/Rel must interact with other regulatory pathways to control expression of cellular genes as EBV drives resting B cells into the cell cycle.</clue>
</event>
<event CL="L2" KT="Analysis" id="E15">
<type class="Correlation"/>
<theme idref="E14"/>
<theme idref="A10"/>
<clue>The EBV-encoded latent membrane protein 1 is capable of transactivating the isolated CD48 NF-kappa B site but not the intact element, <clueKT><clueCL>suggesting</clueCL></clueKT> that the latent membrane protein 1-driven activation of NF-kappa B/Rel must <clueType>interact</clueType> <linkTheme>with</linkTheme> other regulatory pathways to control expression of cellular genes as EBV drives resting B cells into the cell cycle.</clue>
</event>
<event KT="Other" id="E16">
<type class="Gene_expression"/>
<theme idref="A9"/>
<clue>The EBV-encoded latent membrane protein 1 is capable of transactivating the isolated CD48 NF-kappa B site but not the intact element, suggesting that the latent membrane protein 1-driven activation of NF-kappa B/Rel must interact with other regulatory pathways to control <clueType>expression</clueType> <linkTheme>of</linkTheme> cellular genes as EBV drives resting B cells into the cell cycle.</clue>
</event>
<event KT="Other" id="E17" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="E15"/>
<clue>The EBV-encoded latent membrane protein 1 is capable of transactivating the isolated CD48 NF-kappa B site but not the intact element, suggesting that the latent membrane protein 1-driven activation of NF-kappa B/Rel must interact with other regulatory pathways to <clueType>control</clueType> expression of cellular genes as EBV drives resting B cells into the cell cycle.</clue>
</event>
<event KT="Other" id="E18">
<type class="Cellular_physiological_process"/>
<theme idref="A20"/>
<clue>The EBV-encoded latent membrane protein 1 is capable of transactivating the isolated CD48 NF-kappa B site but not the intact element, suggesting that the latent membrane protein 1-driven activation of NF-kappa B/Rel must interact with other regulatory pathways to control expression of cellular genes as EBV drives <clueType>resting</clueType> B cells <clueType>into the cell cycle</clueType>.</clue>
<comment>CAUTION</comment></event>
<event KT="Other" id="E19">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="T35"/>
<clue>The EBV-encoded latent membrane protein 1 is capable of transactivating the isolated CD48 NF-kappa B site but not the intact element, suggesting that the latent membrane protein 1-driven activation of NF-kappa B/Rel must interact with other regulatory pathways to control expression of cellular genes as EBV <clueType>drives</clueType> resting B cells into the cell cycle.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
